{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T02:05:58Z","timestamp":1781316358106,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejogrb.2025.113954","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T09:26:57Z","timestamp":1744018017000},"page":"113954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Clinical Efficacy of Percutaneous Microwave Ablation in Treating Uterine Fibroids: A Comprehensive Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"310","author":[{"given":"Farooq","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha Islam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiza","family":"Asif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudasar","family":"Nisar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faryal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anza","family":"Razzaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdur Rehman","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Azeemuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejogrb.2025.113954_b0005","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.5114\/aoms\/171786","article-title":"Global epidemiological characteristics of uterine fibroids","volume":"19","author":"Li","year":"2023","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.ejogrb.2025.113954_b0010","unstructured":"Barjon K, Mikhail LN. Uterine Leiomyomata. StatPearls. 2023 Aug 7; [accessed 3 Nov 2024]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK546680\/."},{"key":"10.1016\/j.ejogrb.2025.113954_b0015","unstructured":"Cruz MSDD LA, Buchanan EM. Uterine Fibroids: Diagnosis and Treatment. Am Fam Physician. 2017 Jan 15;95(2):100\u20137. [accessed 3 Nov 2024]. Available from: https:\/\/www.aafp.org\/pubs\/afp\/issues\/2017\/0115\/p100.html."},{"key":"10.1016\/j.ejogrb.2025.113954_b0020","doi-asserted-by":"crossref","unstructured":"Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update. 2016 Nov 20;22(6):665\u201386. [accessed 3 Nov 2024] Available from: https:\/\/dx.doi.org\/10.1093\/humupd\/dmw023.","DOI":"10.1093\/humupd\/dmw023"},{"key":"10.1016\/j.ejogrb.2025.113954_b0025","doi-asserted-by":"crossref","unstructured":"Hao Y, Ma X, Zhang J. Microwave Ablation for Symptomatic Uterine Fibroids. Microwave Ablation Treatment of Solid Tumors. 2015 Jan 1;259\u201372. [accessed 3 Nov 2024]. Available from: https:\/\/link.springer.com\/chapter\/10.1007\/978-94-017-9315-5_24.","DOI":"10.1007\/978-94-017-9315-5_24"},{"key":"10.1016\/j.ejogrb.2025.113954_b0030","doi-asserted-by":"crossref","unstructured":"Li Q-Y, Li X-L, Deng E-Y, Yu S-Y, Sun L-P, Zhang H-L, et al. Ultrasound-guided percutaneous microwave ablation for uterine fibroids: mid-term local treatment efficiency and associated influencing factors. Br J Radiol. 2022 Sep 1;95(1137). doi: 10.1259\/bjr.20220039.","DOI":"10.1259\/bjr.20220039"},{"key":"10.1016\/j.ejogrb.2025.113954_b0035","doi-asserted-by":"crossref","unstructured":"Xia J, Teng D, Sui G, Luo Q, Lin Y, Wang H. Effectiveness and Safety of Ultrasound-guided Percutaneous Microwave Ablation for a Single Uterine Fibroid Greater than 300 cm3. J Minim Invasive Gynecol. 2023 Apr 1;30(4):290\u20139. [accessed 3 Nov 2024] Available from: http:\/\/www.jmig.org\/article\/S1553465022010494\/fulltext.","DOI":"10.1016\/j.jmig.2022.12.013"},{"issue":"2018","key":"10.1016\/j.ejogrb.2025.113954_b0040","article-title":"Percutaneous high frequency microwave ablation of uterine fibroids: systematic review","volume":"8","author":"Ierardi","year":"2018","journal-title":"Biomed Res Int"},{"issue":"12","key":"10.1016\/j.ejogrb.2025.113954_b0045","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jmig.2021.06.020","article-title":"Ultrasound-guided microwave ablation in the management of symptomatic uterine Myomas: a systematic review and meta-analysis","volume":"28","author":"Liu","year":"2021","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.ejogrb.2025.113954_b0050","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"29","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.113954_b0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/13645706.2019.1668417","article-title":"Percutaneous microwave ablation of uterine fibroids: correlation between shrinkage and trend symptoms","volume":"30","author":"Ierardi","year":"2021","journal-title":"Minim Invasive Ther Allied Technol"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.113954_b0060","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1080\/02656736.2022.2109764","article-title":"Long term follow-up of uterine fibroids treated with microwave ablation: an up to 3-year observational study of volume, regrowth, and symptoms","volume":"39","author":"Beermann","year":"2022","journal-title":"Int J Hyperth"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.113954_b0065","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/02656736.2022.2034991","article-title":"Ultrasound guided microwave ablation compared to uterine artery embolization treatment for uterine fibroids \u2013 a randomized controlled trial","volume":"39","author":"Jonsdottir","year":"2022","journal-title":"Int J Hyperth"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.113954_b0070","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s00404-023-07334-9","article-title":"Application of transabdominal ultrasound- and laparoscopy-guided percutaneous microwave ablation for treating uterine fibroids: 24-month follow-up outcomes","volume":"309","author":"Chen","year":"2024","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.113954_b0075","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.113954_b0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"10.1016\/j.ejogrb.2025.113954_b0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-052664","article-title":"Uterine Fibroid Symptom and Quality of Life questionnaire (UFS-QOL NL) in the Dutch population: a validation study","volume":"11","author":"Keizer","year":"2021","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.113954_b0090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1477-7525-6-99","article-title":"The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL)","volume":"12","author":"Harding","year":"2008","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ejogrb.2025.113954_b0095","unstructured":"Study Quality Assessment Tools | NHLBI, NIH. [accessed 16 Jun 2024] Available from: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools."},{"issue":"2","key":"10.1016\/j.ejogrb.2025.113954_b0100","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cegh.2018.05.005","article-title":"Interpretation of subgroup analyses in systematic reviews: A tutorial","volume":"7","author":"Richardson","year":"2019","journal-title":"Clin Epidemiol Glob Health"},{"key":"10.1016\/j.ejogrb.2025.113954_b0105","doi-asserted-by":"crossref","unstructured":"Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997 Sep 13;315(7109):629\u201334. [accessed 6 Jul 2024]. Available from: https:\/\/www.bmj.com\/content\/315\/7109\/629.","DOI":"10.1136\/bmj.315.7109.629"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.113954_b0110","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3109\/02656736.2011.562872","article-title":"Ultrasound-guided percutaneous microwave ablation for symptomatic uterine fibroid treatment \u2013 A clinical study","volume":"27","author":"Zhang","year":"2011","journal-title":"Int J Hyperth"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.113954_b0115","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jmig.2013.11.012","article-title":"Ultrasound-Guided Percutaneous Microwave Ablation for Submucosal Uterine Fibroids","volume":"21","author":"Yang","year":"2014","journal-title":"J Minim Invasive Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.113954_b0120","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejrad.2014.11.041","article-title":"A retrospective comparison of microwave ablation and high intensity focused ultrasound for treating symptomatic uterine fibroids","volume":"84","author":"Zhao","year":"2015","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.113954_b0125","first-page":"588","article-title":"Outpatient transcervical microwave myolysis assisted by transabdominal ultrasonic guidance for menorrhagia caused by submucosal myomas","volume":"31","author":"Tsuda","year":"2015","journal-title":"Int J Hyperthermia"},{"issue":"8","key":"10.1016\/j.ejogrb.2025.113954_b0130","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1080\/02656736.2016.1212276","article-title":"Effectiveness of ultrasound-guided percutaneous microwave ablation for symptomatic uterine fibroids: a multicentre study in China","volume":"32","author":"Liu","year":"2016","journal-title":"Int J Hyperth"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.113954_b0135","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jmig.2018.06.014","article-title":"Ultrasound-Guided Percutaneous Microwave Ablation for Subserosal Uterine Myomas","volume":"26","author":"Yang","year":"2019","journal-title":"J Minim Invasive Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.113954_b0140","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jmig.2022.12.013","article-title":"Effectiveness and Safety of Ultrasound-guided Percutaneous Microwave Ablation for a Single Uterine Fibroid Greater than 300 cm3","volume":"30","author":"Xia","year":"2023","journal-title":"J Minim Invasive Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.113954_b0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jvir.2023.09.017","article-title":"An Evaluation of Ultrasound-Guided Percutaneous Microwave Ablation for the Treatment of Symptomatic Uterine Fibroids","volume":"35","author":"Ahmadzade","year":"2024","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.113954_b0150","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/jcu.23438","article-title":"Optimal treatment options for uterine submucosal fibroids: Percutaneous microwave ablation versus transcervical resection of myoma","volume":"51","author":"Jin","year":"2023","journal-title":"J Clin Ultrasound"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.113954_b0155","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3109\/02656736.2011.562872","article-title":"Ultrasound-guided percutaneous microwave ablation for symptomatic uterine fibroid treatment \u2013 A clinical study","volume":"27","author":"Zhang","year":"2011","journal-title":"Int J Hyperth"},{"key":"10.1016\/j.ejogrb.2025.113954_b0160","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2360107","article-title":"Percutaneous High Frequency Microwave Ablation of Uterine Fibroids: Systematic Review","volume":"2018","author":"Ierardi","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ejogrb.2025.113954_b0165","doi-asserted-by":"crossref","unstructured":"Taylor DK, Holthouser K, Segars JH, Leppert PC. Recent scientific advances in leiomyoma (uterine fibroids) research facilitates better understanding and management. F1000Res. 2015 Jul 6;4(F1000 Faculty Rev):183. [accessed 1 Jun 2024] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26236472\/.","DOI":"10.12688\/f1000research.6189.1"},{"key":"10.1016\/j.ejogrb.2025.113954_b0170","doi-asserted-by":"crossref","unstructured":"Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. Am J Obstet Gynecol. 2003 Jan 1;188(1):100\u20137. [accessed 3 Nov 2024]. Available from: http:\/\/www.ajog.org\/article\/S0002937802714294\/fulltext.","DOI":"10.1067\/mob.2003.99"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.113954_b0175","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.fertnstert.2008.01.051","article-title":"Fibroids and infertility: an updated systematic review of the evidence","volume":"91","author":"Pritts","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2025.113954_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2019.108700","article-title":"Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: A systematic review and meta-analysis","volume":"120","author":"Verpalen","year":"2019","journal-title":"Eur J Radiol"},{"issue":"12","key":"10.1016\/j.ejogrb.2025.113954_b0185","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1089\/lap.2019.0550","article-title":"Clinical performance of radiofrequency ablation for treatment of uterine fibroids: systematic review and meta-analysis of prospective studies","volume":"29","author":"Bradley","year":"2019","journal-title":"J Laparoendosc Adv Surg Tech"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.113954_b0190","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s00270-010-9909-8","article-title":"A comparative study of fibroid ablation rates using radio frequency or high-intensity focused ultrasound","volume":"33","author":"Meng","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.113954_b0195","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1080\/02656736.2020.1807617","article-title":"Long-term follow-up outcome and reintervention analysis of ultrasound-guided high intensity focused ultrasound treatment for uterine fibroids","volume":"37","author":"Li","year":"2020","journal-title":"Int J Hyperth"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.113954_b0200","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1080\/02656736.2019.1639832","article-title":"Application of oxytocin in ultrasound-guided percutaneous microwave ablation for treatment of hypervascular uterine fibroids: a preliminary report","volume":"36","author":"Fu","year":"2019","journal-title":"Int J Hyperth"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.113954_b0205","doi-asserted-by":"crossref","first-page":"38.e1","DOI":"10.1016\/j.ajog.2013.09.038","article-title":"Submucosal fibroids and the relation to heavy menstrual bleeding and anemia","volume":"210","author":"Puri","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2025.113954_b0210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/frph.2022.818243","article-title":"Uterine fibroids (leiomyomata) and heavy menstrual bleeding","volume":"4","author":"Uimari","year":"2022","journal-title":"Front Reprod Health"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525002234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525002234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T11:14:48Z","timestamp":1747653288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211525002234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":42,"alternative-id":["S0301211525002234"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.113954","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Efficacy of Percutaneous Microwave Ablation in Treating Uterine Fibroids: A Comprehensive Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.113954","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113954"}}